Johnson County Clin-Trials (JCCT)

Johnson County Clin-Trials (JCCT) has been serving the biotechnology industry since 2005 by providing comprehensive clinical research services to small biotechs and large multinational CROs and Pharma. Specializing in phases I-IV outpatient and inpatient trials, JCCT has an impressive track record, having successfully completed over 100 vaccine trials, including First-in-Man studies and a wide range of platforms, indications, adjuvants, and routes of administration.

Based in the United States, JCCT recently secured a Private Equity Round investment led by Friedman Fleischer & Lowe (FFL) on August 28, 2023. This investment not only underscores the company's potential and market relevance but also signifies a vote of confidence from a reputable investor. With an established reputation and a solid history of successful trials, JCCT is well-positioned to continue driving innovation and making significant contributions to the biotechnology sector.